NanoString announced three new Contract Research Organization CosMxTM Spatial Molecular Imager partnerships. Macrogen, Propath UK, and Sirona Dx offer global biopharma customers new access to CosMx SMI technology for translational drug development. These specialty CROs provide biomarker testing services for drug developers and academic research institutions. Korea-based Macrogen, which provides personalized healthcare services to predict and prevent diseases and provide personalized treatment options for patients, is the first CRO in the Asia-Pacific region to offer both CosMx SMI and GeoMx DSP platforms.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NSTG: